Can NLRP3 (Nucleotide-binding domain, leucine-rich repeat-containing family, pyrin domain-containing 3) activate cytoplasmic DNA?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

NLRP3 can activate in response to cytoplasmic DNA, as it plays a crucial role in the innate immune response, particularly in the recognition of danger-associated molecular patterns (DAMPs) such as mitochondrial DNA (mtDNA) released into the cytosol 1.

Key Points

  • NLRP3 inflammasome is activated by various stimuli, including cytoplasmic DNA, which leads to the cleavage of pro-inflammatory cytokines like IL-1β and IL-18 1.
  • Mitochondrial DNA can be released into the cytosol and activate the NLRP3 inflammasome, triggering an inflammatory response 1.
  • Pattern recognition receptors (PRRs), such as cyclic GMP-AMP synthase (CGAS), recognize cytosolic DNA and activate downstream signaling pathways, including the NLRP3 inflammasome 1.
  • Immunogenic cell death (ICD) inducers can lead to the activation of NLRP3, resulting in the release of immunostimulatory molecules like ATP, HMGB1, and type I IFN, which promote the recruitment and activation of antigen-presenting cells (APCs) and T cells 1.

Relevant Mechanisms

  • The activation of NLRP3 by cytoplasmic DNA involves the recognition of DAMPs by PRRs, leading to the assembly of the inflammasome complex and the cleavage of pro-inflammatory cytokines.
  • The NLRP3 inflammasome plays a critical role in the innate immune response, particularly in the recognition of microbial and host-derived DAMPs.

From the Research

NLRP3 Activation

  • The NLRP3 inflammasome is a cytoplasmic protein complex that mediates inflammatory responses to a broad array of danger signals 2.
  • NLRP3 senses pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs), and activates caspase-1, which provokes release of proinflammatory cytokines such as interleukin-1β (IL-1β) and IL-18 as well as pyroptosis to engage in innate immune defense 3.

Role of DNA in NLRP3 Activation

  • Intracellular mitochondrial DNA (mtDNA) can be oxidized and transferred to the cytoplasm, where it directly binds to NLRP3 to activate the NLRP3 inflammasome 4.
  • The NLRP3 inflammasome affects DNA damage responses after oxidative and genotoxic stress in dendritic cells, with Nlrp3(-/-) DCs experiencing significantly less oxidative DNA damage mediated by ROS 2.
  • There is no direct evidence that NLRP3 can activate cytoplasmic DNA, but it can be activated by mitochondrial DNA and other danger signals.

Mechanism of NLRP3 Activation

  • The leucine-rich repeat (LRR) domain of NLRP3 is required for NLRP3 inflammasome activation in macrophages, with deletion of the LRR domain inhibiting NLRP3 self-association, oligomerization, and interaction with the essential regulator NEK7 5.
  • The endoplasmic reticulum (ER) plays a critical role in NLRP3 inflammasome activation, with ER-mitochondria contact sites providing a location for NLRP3 activation and ER-stress signaling contributing to NLRP3 inflammasome activation 3.

Related Questions

Can NLRP3 (Nucleotide-binding domain, leucine-rich repeat-containing family, pyrin domain-containing 3) inflammasome activation contribute to an elevated Coronary Artery Calcium (CAC) score?
Can NLRP3 (Nucleotide-binding domain, leucine-rich repeat-containing family, pyrin domain-containing 3) directly or indirectly cause symptoms such as paresthesia (tingling) and numbness of the lower extremities, neurogenic bladder dysfunction, fecal incontinence, sexual anhedonia, occasional thermoregulatory dysfunction, and balance disturbances?
Can NLRP3 (Nucleotide-binding domain, leucine-rich repeat-containing family, pyrin domain-containing 3) increase cystatin C levels?
Can NLRP3 (Nucleotide-binding domain, leucine-rich repeat-containing family, pyrin domain-containing 3) lead to anorgasmia?
Can NLRP3 (Nucleotide-binding domain, leucine-rich repeat-containing family, pyrin domain-containing 3) activation cause sexual anhedonia, urinary retention, fecal incontinence, and numbness and tingling of the lower extremities?
What are the key assessment findings and treatment options for a 27-year-old female presenting with burns to her left hand and forearm from a coffee machine?
What is the connection between cytoplasmic Deoxyribonucleic acid (DNA) and Interleukin-1 beta (IL-1β) and Interleukin-18 (IL-18)?
What conditions are associated with fasciculations?
What is the diagnosis and management of Benign Neutropenia (a condition characterized by a low neutrophil count) in children?
What genes are associated with fasciculations?
What are non-stimulant Attention Deficit Hyperactivity Disorder (ADHD) medication options?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.